HIGHFDA DEVICE

Biomerieux Recalls VITEK 2 Antibiotic Susceptibility Cards Due to False Results

Biomerieux recalled 2,668,954 VITEK 2 Gram-negative susceptibility cards on January 5, 2026. The recall addresses potential false resistant results for certain antibiotic tests. Healthcare providers and patients must stop using the product immediately.

Official notice
BiomerieuxHealth & Personal CareMedical DevicesAll lot codes of the identified Gram-negative AST test kits.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
January 5, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 5, 2026
Hazard Level
HIGH
Brand
Biomerieux
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Biomerieux
Product type
Antibiotic Susceptibility Testing Cards
Model numbers
All lot codes of the identified Gram-negative AST test kits.
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 5, 2026

  2. Reported by FDA DEVICE

    February 11, 2026

  3. RecallRadar source check

    February 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobacterales/Enterobacteriaceae species and/or Pseudomonas aeruginosa with the identified antibiotic formulations. Issue may lead to QC failure or false resistant results.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Biomerieux Inc or your healthcare provider for instructions. Notification method: Letter

About This Product

The VITEK 2 Gram-negative susceptibility cards are used in laboratories to determine the sensitivity of bacteria to various antibiotics. Laboratories and healthcare providers rely on accurate results for effective treatment of infections.

Why This Is Dangerous

The identified hazard involves potential inaccuracies in test results, which may lead to inappropriate antibiotic usage and ineffective treatment plans. This can result in serious health risks for patients.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers and healthcare providers must be vigilant about the use of these cards, as incorrect test results can compromise patient safety and treatment efficacy.

Practical Guidance

How to identify if yours is affected

  1. Check the product packaging for lot codes to determine if your cards are affected.
  2. Contact your healthcare provider for additional verification if needed.
  3. Review any notification letters from Biomerieux regarding the recall.

Where to find product info

Lot codes can typically be found on the packaging of the susceptibility cards or in accompanying documentation.

What timeline to expect

Expect a refund or replacement process to take approximately 4-6 weeks after returning the product.

If the manufacturer is unresponsive

  • Document your communication attempts and keep records of correspondence.
  • Escalate the issue by contacting consumer protection agencies if the company does not respond.

How to prevent similar issues

  • When purchasing medical devices, look for FDA approval and quality assurance certifications.
  • Regularly check for product recalls and safety notices from manufacturers and government agencies.

Documentation advice

Keep records of your purchase, any communication with the manufacturer, and photos of the product as evidence.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall includes all lot codes of the VITEK 2 Gram-negative susceptibility cards. The affected products were distributed worldwide, including the United States.

Key Facts

  • Recall date: January 5, 2026
  • Affected species: Enterobacterales/Enterobacteriaceae and Pseudomonas aeruginosa
  • Class II recall due to high hazard level

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeAntibiotic Susceptibility Testing Cards
Sold At
Unknown

Product Details

Model Numbers
All lot codes of the identified Gram-negative AST test kits.
Affected States
ALL
Report Date
February 11, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more